Patent details

EP2043659 Title: ANTI-CANCER THERAPY COMPRISING AN H2-BLOCKER, AT LEAST ONE ANTIINFLAMMATORY AGENT AND A CYTOTOXIC AGENT.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2043659
WO Application Number:
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP07766866.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Israel (IL)
Publications:

Dates

Filing date:
04/07/2007
Grant date:
03/04/2013
EP Publication Date:
03/04/2013
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/08/2017
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
03/04/2013
EP B1 Publication Date:
03/04/2013
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
24/06/2013
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
03/07/2027
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
03/04/2013
 
 

 

Name:
Tiltan Pharma Ltd
Address:
1-1 Hi-Tech Village Edmond Safra Campus Givat Ram P.O.B. 39026, 91390 JERUSALEM, Israel (IL)

Inventor

Name:
BEN-SASSON, Shmuel A.
Address:
96343 JERUSALEM, Israel (IL)

Priority

1

Priority Patent Number:
880107 P
Priority Date:
12/01/2007
Priority Country:
United States of America (US)

2

Priority Patent Number:
819164 P
Priority Date:
07/07/2006
Priority Country:
United States of America (US)

Classification

Main IPC Class:
A61K 31/675;
IPC or IDT classification:
A61K 31/196; A61K 31/203; A61K 31/415; A61K 31/425; A61K 31/4402; A61K 45/06; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
11/18
Publication date:
07/03/2018
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
2013/35
Publication date:
28/08/2013
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
2013/15
Publication date:
10/04/2013
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201314
Publication date:
03/04/2013
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
25/07/2016
Last Annual Fee Paid Number:
10
Last Annual Fee Paid Amount:
400 Euro
Payer:
IPAN GmbH
Filing date Document type Document Description Number of pages File Type
20/06/2016 Outgoing Correspondence Outgoing Letter 1 PDF /6/6/8/6/6/0507766866/docs/ep07766866.3_4_62842l181.pdf
16/08/2013 Outgoing Correspondence Outgoing Letter 1 PDF /6/6/8/6/6/0507766866/docs/ep07766866.3_2_outgoingcorrespondence20130816.pdf
24/06/2013 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /6/6/8/6/6/0507766866/docs/ep07766866.3_0_incomingcorrespondencepaper20130624.pdf
24/06/2013 Outgoing Correspondence Outgoing Letter 1 PDF /6/6/8/6/6/0507766866/docs/ep07766866.3_1_outgoingcorrespondence20130624.pdf
24/06/2013 Claims Translated claims 1 PDF /6/6/8/6/6/0507766866/docs/ep07766866.3_3_claims20130624.pdf